Pediatr Ann. 2022 Feb;51(2):e77-e81. doi: 10.3928/19382359-20220113-01. Epub 2022 Feb 1.

Julia Kleinhenz, Ellen Wagner

Author information

Abstract

Inflammatory bowel diseases (IBD) consist of Crohn's disease and ulcerative colitis. These are conditions that, although managed by pediatric gastroenterologists, are encountered frequently by the general pediatrician. The purpose of this article is to review the use of targeted antibody treatments, also known as biologics, in the treatment of pediatric IBD as well as complications and adverse effects for the pediatrician to consider when caring for a patient with IBD who is taking biologics.